Centre de Recherche du Centre Hospitalier de l'Universite de Montreal (CRCHUM)

Montreal

0 studies enrolling now · 1 studies all time

What they study most

Antibody-mediated Rejection

Studies at this site

• Clazakizumab for the Treatment of Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients — Stopped early